These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Growth hormone: who can benefit from it?].
    Author: Schwarz HP.
    Journal: Ther Umsch; 1995 Oct; 52(10):678-81. PubMed ID: 7482379.
    Abstract:
    Recombinant human growth hormone (GH) has become available in unlimited quantities. Classic indications for GH therapy include GH deficiency of childhood and adult onset, Turner syndrome and chronic renal insufficiency. Nonclassic indications for GH use are short stature without GH deficiency, catabolic states, severe burns, osteoporosis. Controlled studies are necessary to prove a potential benefit of GH in nonclassic or new situations. The prescription of GH should be supervised by specialists to ensure that this expensive drug is used judiciously.
    [Abstract] [Full Text] [Related] [New Search]